Taking everything into account, CRKN scores 2 out of 10 in our fundamental rating. CRKN was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of CRKN have multiple concerns. CRKN is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CRKN has reported negative net income.
CRKN had a negative operating cash flow in the past year.
In the past 5 years CRKN always reported negative net income.
In the past 5 years CRKN always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -202.17%, CRKN is not doing good in the industry: 95.29% of the companies in the same industry are doing better.
CRKN has a worse Return On Equity (-359.07%) than 91.76% of its industry peers.

		Industry Rank	Sector Rank
ROA	-202.17%
ROE	-359.07%
ROIC	N/A

ROA(3y)-253.99%

ROA(5y)-773.83%

ROE(3y)-1197.06%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CRKN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CRKN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRKN has more shares outstanding than it did 1 year ago.
CRKN has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -13.73, we must say that CRKN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRKN (-13.73) is worse than 85.88% of its industry peers.
CRKN has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
CRKN has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. CRKN outperforms 91.76% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-13.73

ROIC/WACCN/A

WACC8.02%

2.3 Liquidity

CRKN has a Current Ratio of 1.40. This is a normal value and indicates that CRKN is financially healthy and should not expect problems in meeting its short term obligations.
CRKN's Current ratio of 1.40 is on the low side compared to the rest of the industry. CRKN is outperformed by 65.88% of its industry peers.
CRKN has a Quick Ratio of 1.40. This is a normal value and indicates that CRKN is financially healthy and should not expect problems in meeting its short term obligations.
CRKN has a Quick ratio of 1.40. This is in the better half of the industry: CRKN outperforms 63.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.4
Quick Ratio	1.4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CRKN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -5905.53%.
Looking at the last year, CRKN shows a very strong growth in Revenue. The Revenue has grown by 23871.19%.
The Revenue has been growing by 15.23% on average over the past years. This is quite good.

EPS 1Y (TTM)-5905.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-19958.51%

Revenue 1Y (TTM)23871.19%

Revenue growth 3Y15.23%

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.